{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:49:09Z","timestamp":1791838149051,"version":"4.3.4"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100012319","name":"National Center for Global Health and Medicine","doi-asserted-by":"publisher","award":["20A1020"],"award-info":[{"award-number":["20A1020"]}],"id":[{"id":"10.13039\/100012319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012319","name":"National Center for Global Health and Medicine","doi-asserted-by":"publisher","award":["21A1014"],"award-info":[{"award-number":["21A1014"]}],"id":[{"id":"10.13039\/100012319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012319","name":"National Center for Global Health and Medicine","doi-asserted-by":"publisher","award":["23A2004"],"award-info":[{"award-number":["23A2004"]}],"id":[{"id":"10.13039\/100012319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Mycoplasma genitalium, which causes sexually transmitted diseases, is increasingly resistant to key antibiotics such as macrolides and quinolones, posing a challenge for treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To assess the effectiveness of prolonged sitafloxacin and doxycycline combination therapy as a new alternative treatment strategy for highly drug-resistant M. genitalium strains<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A prospective cohort study was conducted at the National Center for Global Health and Medicine, Tokyo, Japan, from 1 January 2020 to 31 October 2022. Patients with M. genitalium urogenital or rectal infections and those who did not receive the initial sitafloxacin monotherapy were included. Patients were administered sitafloxacin and doxycycline for 21\u2005days as salvage therapy. M. genitalium isolates were tested for parC, gyrA and 23S rRNA resistance-associated mutations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Twenty-seven patients received the combination therapy. All M. genitalium strains available for resistance analysis had parC (24\/24) and macrolide resistance-associated (25\/25) mutations, and 68% (17\/25) had gyrA mutations. The overall cure rate was 77.8%. For strains with concurrent parC and gyrA mutations, the cure rate was 68.8% (P\u200a=\u200a0.053) compared with that for monotherapy (37.5%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Prolonged combination therapy is highly effective against M. genitalium strains with concurrent parC and gyrA mutations. Future research should focus on establishing the optimal treatment duration and monitoring the risk of resistance.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkae403","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T15:48:43Z","timestamp":1730821723000},"page":"247-253","source":"Crossref","is-referenced-by-count":8,"title":["Prolonged sitafloxacin and doxycycline combination regimen for treating infections by highly resistant <i>Mycoplasma genitalium<\/i>"],"prefix":"10.1093","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5520-2780","authenticated-orcid":false,"given":"Naokatsu","family":"Ando","sequence":"first","affiliation":[{"name":"AIDS Clinical Center, National Center for Global Health and Medicine , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8424-4616","authenticated-orcid":false,"given":"Daisuke","family":"Mizushima","sequence":"additional","affiliation":[{"name":"AIDS Clinical Center, National Center for Global Health and Medicine , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misao","family":"Takano","sequence":"additional","affiliation":[{"name":"AIDS Clinical Center, National Center for Global Health and Medicine , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morika","family":"Mitobe","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Tokyo Metropolitan Institute for Public Health , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Tokyo Metropolitan Institute for Public Health , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6339-8568","authenticated-orcid":false,"given":"Hiroaki","family":"Kubota","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Tokyo Metropolitan Institute for Public Health , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Miyake","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Tokyo Metropolitan Institute for Public Health , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Tokyo Metropolitan Institute for Public Health , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Sadamasu","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Tokyo Metropolitan Institute for Public Health , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Aoki","sequence":"additional","affiliation":[{"name":"AIDS Clinical Center, National Center for Global Health and Medicine , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3190-8439","authenticated-orcid":false,"given":"Koji","family":"Watanabe","sequence":"additional","affiliation":[{"name":"AIDS Clinical Center, National Center for Global Health and Medicine , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Oka","sequence":"additional","affiliation":[{"name":"AIDS Clinical Center, National Center for Global Health and Medicine , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Gatanaga","sequence":"additional","affiliation":[{"name":"AIDS Clinical Center, National Center for Global Health and Medicine , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"key":"2025010309481722200_dkae403-B1","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1128\/CMR.00006-11","article-title":"Mycoplasma genitalium: from chrysalis to multicolored butterfly","volume":"24","author":"Taylor-Robinson","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"2025010309481722200_dkae403-B2","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/S1473-3099(20)30154-7","article-title":"Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis","volume":"20","author":"Machalek","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"2025010309481722200_dkae403-B3","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/cid\/ciz294","article-title":"Mycoplasma genitalium in symptomatic male urethritis: macrolide use is associated with increased resistance","volume":"70","author":"Li","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025010309481722200_dkae403-B4","doi-asserted-by":"publisher","first-page":"115854","DOI":"10.1016\/j.diagmicrobio.2022.115854","article-title":"Emerging multidrug resistance contributes to treatment failure in Mycoplasma genitalium infected patients in China","volume":"105","author":"Li","year":"2023","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2025010309481722200_dkae403-B5","doi-asserted-by":"publisher","first-page":"dlab091","DOI":"10.1093\/jacamr\/dlab091","article-title":"High prevalence of circulating dual-class resistant Mycoplasma genitalium in asymptomatic MSM in Tokyo, Japan","volume":"3","author":"Ando","year":"2021","journal-title":"JAC Antimicrob Resist"},{"key":"2025010309481722200_dkae403-B6","doi-asserted-by":"publisher","first-page":"2300318","DOI":"10.2807\/1560-7917.ES.2024.29.7.2300318","article-title":"Estimation of antimicrobial resistance of Mycoplasma genitalium, Belgium, 2022","volume":"29","author":"De Baetselier","year":"2024","journal-title":"Euro Surveill"},{"key":"2025010309481722200_dkae403-B7","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1093\/cid\/ciad405","article-title":"Mycoplasma genitalium in the US (MyGeniUS): surveillance data from sexual health clinics in 4 US regions","volume":"77","author":"Manhart","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2025010309481722200_dkae403-B8","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/infdis\/jiz550","article-title":"Moxifloxacin and sitafloxacin treatment failure in Mycoplasma genitalium infection: association with parC mutation G248 T (S83I) and concurrent gyrA mutations","volume":"221","author":"Murray","year":"2020","journal-title":"J Infect Dis"},{"key":"2025010309481722200_dkae403-B9","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1093\/cid\/ciad057","article-title":"gyrA mutations in Mycoplasma genitalium and their contribution to moxifloxacin failure: time for the next generation of resistance-guided therapy","volume":"76","author":"Murray","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2025010309481722200_dkae403-B10","doi-asserted-by":"publisher","first-page":"e0198355","DOI":"10.1371\/journal.pone.0198355","article-title":"Mutations in parC and gyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains","volume":"13","author":"Hamasuna","year":"2018","journal-title":"PLoS One"},{"key":"2025010309481722200_dkae403-B11","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3201\/eid2305.161745","article-title":"Increasing macrolide and fluoroquinolone resistance in Mycoplasma genitalium","volume":"23","author":"Murray","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"2025010309481722200_dkae403-B12","doi-asserted-by":"publisher","first-page":"e0027822","DOI":"10.1128\/aac.00278-22","article-title":"parC variants in Mycoplasma genitalium: trends over time and association with moxifloxacin failure","volume":"66","author":"Murray","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"2025010309481722200_dkae403-B13","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1093\/jac\/dkad208","article-title":"Effectiveness of sitafloxacin monotherapy for quinolone-resistant rectal and urogenital Mycoplasma genitalium infections: a prospective cohort study","volume":"78","author":"Ando","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"2025010309481722200_dkae403-B14","doi-asserted-by":"publisher","first-page":"100737","DOI":"10.1016\/j.lanepe.2023.100737","article-title":"Treatment of bacterial sexually transmitted infections in Europe: gonorrhoea, Mycoplasma genitalium, and syphilis","volume":"34","author":"Mitj\u00e0","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"2025010309481722200_dkae403-B15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12941-023-00627-6","article-title":"Global analysis on the mutations associated with multidrug-resistant urogenital mycoplasmas and ureaplasmas infection: a systematic review and meta-analysis","volume":"22","author":"Abavisani","year":"2023","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"2025010309481722200_dkae403-B16","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1136\/sextrans-2022-055687","article-title":"Prevalence of Mycoplasma genitalium infection among HIV PrEP users: a systematic review and meta-analysis","volume":"99","author":"Sokoll","year":"2023","journal-title":"Sex Transm Infect"},{"key":"2025010309481722200_dkae403-B17","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1177\/09564624231160676","article-title":"Prevalence of Mycoplasma genitalium infection with antimicrobial resistance mutations among gay sex workers in China","volume":"34","author":"Wang","year":"2023","journal-title":"Int J STD AIDS"},{"key":"2025010309481722200_dkae403-B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm Rep"},{"key":"2025010309481722200_dkae403-B19","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1093\/cid\/ciy477","article-title":"Outcomes of resistance-guided sequential treatment of Mycoplasma genitalium infections: a prospective evaluation","volume":"68","author":"Read","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2025010309481722200_dkae403-B20","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/cid\/ciz1031","article-title":"Resistance-guided antimicrobial therapy using doxycycline-moxifloxacin and doxycycline-2.5 g azithromycin for the treatment of Mycoplasma genitalium infection: efficacy and tolerability","volume":"71","author":"Durukan","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025010309481722200_dkae403-B21","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.jiac.2021.07.007","article-title":"UAA-AAUS guideline for M. genitalium and non-chlamydial non-gonococcal urethritis","volume":"27","author":"Wada","year":"2021","journal-title":"J Infect Chemother"},{"key":"2025010309481722200_dkae403-B22","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.3201\/eid2608.191806","article-title":"Doxycycline and sitafloxacin combination therapy for treating highly resistant Mycoplasma genitalium","volume":"26","author":"Durukan","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"2025010309481722200_dkae403-B23","doi-asserted-by":"publisher","first-page":"ofad427","DOI":"10.1093\/ofid\/ofad427","article-title":"Efficacy of minocycline for the treatment of Mycoplasma genitalium","volume":"10","author":"Clarke","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2025010309481722200_dkae403-B24","doi-asserted-by":"publisher","first-page":"ofaa291","DOI":"10.1093\/ofid\/ofaa291","article-title":"Nonquinolone options for the treatment of Mycoplasma genitalium in the era of increased resistance","volume":"7","author":"Doyle","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2025010309481722200_dkae403-B25","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3201\/eid2402.170902","article-title":"Use of pristinamycin for macrolide-resistant Mycoplasma genitalium infection","volume":"24","author":"Read","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"2025010309481722200_dkae403-B26","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1186\/s12879-021-06910-1","article-title":"Evaluation of treatment with two weeks of doxycycline on macrolide-resistant strains of Mycoplasma genitalium: a retrospective observational study","volume":"21","author":"Goss\u00e9","year":"2021","journal-title":"BMC Infect Dis"},{"key":"2025010309481722200_dkae403-B27","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1086\/593188","article-title":"Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance","volume":"47","author":"Jensen","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2025010309481722200_dkae403-B28","doi-asserted-by":"publisher","first-page":"4876","DOI":"10.1128\/JCM.42.10.4876-4878.2004","article-title":"Single-nucleotide polymorphisms in the rRNA operon and variable numbers of tandem repeats in the lipoprotein gene among Mycoplasma genitalium strains from clinical specimens","volume":"42","author":"Ma","year":"2004","journal-title":"J Clin Microbiol"},{"key":"2025010309481722200_dkae403-B29","doi-asserted-by":"publisher","first-page":"904494","DOI":"10.3389\/fmicb.2022.904494","article-title":"Molecular tools for typing Mycoplasma pneumoniae and Mycoplasma genitalium","volume":"13","author":"Dumke","year":"2022","journal-title":"Front Microbiol"},{"key":"2025010309481722200_dkae403-B30","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1177\/0956462416688562","article-title":"Meta-analysis of the efficacy of moxifloxacin in treating Mycoplasma genitalium infection","volume":"28","author":"Li","year":"2017","journal-title":"Int J STD AIDS"},{"key":"2025010309481722200_dkae403-B31","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s10156-011-0329-8","article-title":"Antimicrobial efficacies of several antibiotics against uterine cervicitis caused by Mycoplasma genitalium","volume":"18","author":"Terada","year":"2012","journal-title":"J Infect Chemother"},{"key":"2025010309481722200_dkae403-B32","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/1471-2180-8-130","article-title":"Short tandem repeat sequences in the Mycoplasma genitalium genome and their use in a multilocus genotyping system","volume":"8","author":"Ma","year":"2008","journal-title":"BMC Microbiol"},{"key":"2025010309481722200_dkae403-B33","author":"BASHH Clinical Effectiveness Group"},{"key":"2025010309481722200_dkae403-B34","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1136\/sextrans-2023-055900","article-title":"Changes in prevalence of Mycoplasma genitalium macrolide and fluoroquinolone resistance: notes from a 13-year retrospective survey in Dalarna County, Sweden","volume":"99","author":"Drud","year":"2023","journal-title":"Sex Transm Infect"},{"key":"2025010309481722200_dkae403-B35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1136\/sextrans-2019-054386","article-title":"Macrolide and fluoroquinolone resistance of Mycoplasma genitalium in southern Spain, 2018\u20132019","volume":"97","author":"de Salazar","year":"2021","journal-title":"Sex Transm Infect"},{"key":"2025010309481722200_dkae403-B36","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.1093\/jac\/dkv246","article-title":"Time to eradication of Mycoplasma genitalium after antibiotic treatment in men and women","volume":"70","author":"Falk","year":"2015","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/80\/1\/247\/60430204\/dkae403.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/80\/1\/247\/60430204\/dkae403.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T09:48:25Z","timestamp":1735897705000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/80\/1\/247\/7876337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,11,5]]},"published-print":{"date-parts":[[2025,1,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkae403","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2024,11,5]]}}}